These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2845770)

  • 21. High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancer.
    Johnson DH; DeLeo MJ; Hande KR; Wolff SN; Hainsworth JD; Greco FA
    J Clin Oncol; 1987 May; 5(5):703-9. PubMed ID: 3033161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.
    Komaki R; Shin DM; Glisson BS; Fossella FV; Murphy WK; Garden AS; Oswald MJ; Hong WK; Roth JA; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):807-11. PubMed ID: 7860392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.
    Smith IE; Perren TJ; Ashley SA; Woodiwiss J; Forgeson GV; Yarnold JR; Ford HT
    J Clin Oncol; 1990 May; 8(5):899-905. PubMed ID: 2159056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II study.
    Mavroudis D; Pavlakou G; Blazoyiannakis G; Veslemes M; Apostolopoulou F; Kouroussis Ch; Kakolyris S; Agelaki S; Androulakis N; Vardakis N; Magkanas E; Samonis G; Georgoulias V
    Lung Cancer; 2003 Jan; 39(1):71-6. PubMed ID: 12499097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous chemoradiotherapy with irinotecan and cisplatin in limited disease small cell lung cancer: a phase I study.
    Klautke G; Fähndrich S; Semrau S; Büscher C; Virchow C; Fietkau R
    Lung Cancer; 2006 Aug; 53(2):183-8. PubMed ID: 16757061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer.
    Aisner J; Whitacre MY; Budman DR; Propert K; Strauss G; Van Echo DA; Perry M
    Cancer Chemother Pharmacol; 1992; 29(6):435-8. PubMed ID: 1314712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer.
    Hanna N; Bunn PA; Langer C; Einhorn L; Guthrie T; Beck T; Ansari R; Ellis P; Byrne M; Morrison M; Hariharan S; Wang B; Sandler A
    J Clin Oncol; 2006 May; 24(13):2038-43. PubMed ID: 16648503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancer.
    Murphy PB; Hainsworth JD; Greco FA; Hande KR; DeVore RF; Johnson DH
    Cancer; 1992 Jan; 69(2):370-5. PubMed ID: 1309432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group.
    Johnson DH; Turrisi AT; Chang AY; Blum R; Bonomi P; Ettinger D; Wagner H
    J Clin Oncol; 1993 May; 11(5):879-84. PubMed ID: 8387577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective randomized phase III trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small-cell lung cancer.
    Artal-Cortés A; Gomez-Codina J; Gonzalez-Larriba JL; Barneto I; Carrato A; Isla D; Camps C; Garcia-Giron C; Font A; Meana A; Lomas M; Vadell C; Arrivi A; Alonso C; Maestu I; Campbell J; Rosell R
    Clin Lung Cancer; 2004 Nov; 6(3):175-83. PubMed ID: 15555219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer.
    Tabata M; Kiura K; Okimoto N; Segawa Y; Shinkai T; Yonei T; Kuyama S; Harita S; Hotta K; Ueoka H; Tanimoto M
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):1-6. PubMed ID: 17393168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged administration of oral etoposide plus cisplatin in extensive stage small cell lung cancer.
    Greco FA; Murphy PB; Hainsworth JD; Hande KR; Johnson DH
    Oncology; 1992; 49 Suppl 1():34-8; discussion 39. PubMed ID: 1323810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer.
    Bishop JF; Kefford R; Raghavan D; Zalcberg J; Stuart-Harris R; Ball D; Olver IN; Friedlander M; Bull C; Yuen K
    Cancer Chemother Pharmacol; 1990; 25(5):367-70. PubMed ID: 2155064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer.
    Johnson FM; Kurie JM; Peeples BO; Lee JJ; Feng L; Pisters KM; Fossella FV; Papadimitrakopoulou VA; Blumenschein GR; Komaki R; Glisson BS
    Clin Lung Cancer; 2003 Jul; 5(1):40-5. PubMed ID: 14596703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of oral etoposide plus cisplatin in extensive stage small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study.
    Schiller JH; Ettinger DS; Larson MM; Gradishar W; Merkel D; Johnson DH
    Eur J Cancer; 1994; 30A(2):158-61. PubMed ID: 8155389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial.
    Schiller JH; Kim K; Hutson P; DeVore R; Glick J; Stewart J; Johnson D
    J Clin Oncol; 1996 Aug; 14(8):2345-52. PubMed ID: 8708727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
    Mok TS; Wong H; Zee B; Yu KH; Leung TW; Lee TW; Yim A; Chan AT; Yeo W; Chak K; Johnson P
    Cancer; 2002 Oct; 95(7):1511-9. PubMed ID: 12237920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential versus alternating administration of cisplatin/etoposide and topotecan as first-line treatment in extensive-stage small-cell lung cancer: preliminary results of a Phase III Trial of the Hellenic Oncology Research Group.
    Ignatiadis M; Mavroudis D; Veslemes M; Boukovinas J; Syrigos K; Agelidou M; Agelidou A; Gerogianni A; Pavlakou G; Tselepatiotis E; Nikolakopoulos J; Georgoulias V
    Clin Lung Cancer; 2005 Nov; 7(3):183-9. PubMed ID: 16354313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
    Kakolyris S; Agelidou A; Androulakis N; Tsaroucha E; Kouroussis Ch; Agelidou M; Karvounis N; Veslemes M; Christophylakis Ch; Argyraki A; Geroyianni A; Georgoulias V
    Lung Cancer; 2006 Jul; 53(1):59-65. PubMed ID: 16716447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etoposide, cisplatin and doxorubicin in patients with small cell lung cancer: tumor response and long term survival.
    Alberto P; Mermillod B; Joss R; Obrecht JP; Martz G; Kaplan S; Cavalli F
    Eur J Cancer Clin Oncol; 1986 Jun; 22(6):701-8. PubMed ID: 3017722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.